Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maher

Showing results (1131-1140 of 1,158) with videos related to

Pageof 116
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 4, 2024
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory AgencyGanesh Raghu, Marya Ghazipura, Thomas R Fleming, et al.
The Lancet. Infectious Diseases|March 13, 2016
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysisFrancisco M Marty, Luis Ostrosky-Zeichner, Oliver A Cornely, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
American Journal of Respiratory and Critical Care Medicine|March 30, 2022
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group PerspectiveVincent Cottin, Sara Tomassetti, Claudia Valenzuela, et al.
Thorax|November 18, 2016
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosisEric W F W Alton, Jeffery M Beekman, A Christopher Boyd, et al.
European Heart Journal|February 5, 2023
Long-term cardiometabolic health in people born after assisted reproductive technology: a multi-cohort analysisAhmed Elhakeem, Amy E Taylor, Hazel M Inskip, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
A statistical Model for Lung Function Trajectory and Mortality in Patients with Fibrotic Interstitial Lung DiseaseBarbara Wendelberger, Thomas P Jensen, Melanie Quintana, et al.
American Journal of Respiratory and Critical Care Medicine|April 29, 2022
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineGanesh Raghu, Martine Remy-Jardin, Luca Richeldi, et al.
American Journal of Respiratory and Critical Care Medicine|July 14, 2026
Acute exacerbation in fibrotic interstitial lung disease: An International Working Group ReportYet H Khor, Fabrizio Luppi, Ayodeji Adegunsoye, et al.
Acta Neuropathologica|April 19, 2020
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibitionGourish Mondal, Julieann C Lee, Ajay Ravindranathan, et al.
Pageof 116

Showing results (1131-1140 of 1,158) with videos related to

Sort By:
Pageof 116
American Journal of Respiratory and Critical Care Medicine|January 4, 2024
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory AgencyGanesh Raghu, Marya Ghazipura, Thomas R Fleming, et al.
The Lancet. Infectious Diseases|March 13, 2016
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysisFrancisco M Marty, Luis Ostrosky-Zeichner, Oliver A Cornely, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
American Journal of Respiratory and Critical Care Medicine|March 30, 2022
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group PerspectiveVincent Cottin, Sara Tomassetti, Claudia Valenzuela, et al.
Thorax|November 18, 2016
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosisEric W F W Alton, Jeffery M Beekman, A Christopher Boyd, et al.
European Heart Journal|February 5, 2023
Long-term cardiometabolic health in people born after assisted reproductive technology: a multi-cohort analysisAhmed Elhakeem, Amy E Taylor, Hazel M Inskip, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
A statistical Model for Lung Function Trajectory and Mortality in Patients with Fibrotic Interstitial Lung DiseaseBarbara Wendelberger, Thomas P Jensen, Melanie Quintana, et al.
American Journal of Respiratory and Critical Care Medicine|April 29, 2022
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineGanesh Raghu, Martine Remy-Jardin, Luca Richeldi, et al.
American Journal of Respiratory and Critical Care Medicine|July 14, 2026
Acute exacerbation in fibrotic interstitial lung disease: An International Working Group ReportYet H Khor, Fabrizio Luppi, Ayodeji Adegunsoye, et al.
Acta Neuropathologica|April 19, 2020
Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibitionGourish Mondal, Julieann C Lee, Ajay Ravindranathan, et al.
Pageof 116